Global Platelet Rich Plasma (PLP) Market $385 Million by 2021

The global platelet rich plasma (PLP) market is estimated to reach $385 Million in 2021, growing at a CAGR of 11.5% from 2017 to 2021, according to a market research report Platelet Rich Plasma Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.

The global platelet rich plasma market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global platelet rich plasma market segmentation is based on product types (leukocyte-platelet rich fibrin, leukocyte-platelet rich plasma, pure-platelet rich plasma), source types (allogenic, autologus, homologus), and applications (cosmetic surgery, general surgery, neurosurgery, orthopedic surgery, and surgeries like oral and maxillofacial, cardiothoracic, periodontal, urological).

The global platelet rich plasma market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global platelet rich plasma market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Platelet Rich Plasma Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/platelet-rich-plasma-market/

1. Product Type
1.1. Leukocyte-Platelet Rich Fibrin (L-PRF)
1.2. Leukocyte-Platelet Rich Plasma (L-PRP)
1.3. Pure-Platelet Rich Plasma (P-PRP)

2. Source Type
2.1. Allogenic
2.2. Autologus
2.3. Homologus

3. Application
3.1. Cosmetic Surgery
3.2. General Surgery
3.3. Neurosurgery
3.4. Orthopedic Surgery
3.5. Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal, Urological, etc.)

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. AdiStem Ltd.
5.2. Arteriocyte Medical Systems, Inc.
5.3. Arthrex, Inc.
5.4. Biomet, Inc.
5.5. Cesca Therapeutics, Inc.
5.6. DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
5.7. Dr. PRP America LLC
5.8. EmCyte Corporation
5.9. Exactech, Inc.
5.10. Harvest Technologies Corp.
5.11. Nuo Therapeutics, Inc. (Cytomedix, Inc.)
5.12. Regen Lab SA
5.13. Stryker Corporation

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/platelet-rich-plasma-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.